Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-19

Clinical Trial Update: Sildenafil Treatment for Mild TBI [Phase 2]

View source ↗

Summary

Phase 2 trial update on sildenafil for mild traumatic brain injury has been terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Vascular System Injuries, Concussion, Brain | Phase 2 | Status: TERMINATED | Results posted: 2020-11-19